Skip to main content

Patel Sanj K's Form 4 filing

Kiniksa Pharmaceuticals International, plc (KNSA) · filed Apr 30, 2026

Accession no.
0001532218-26-000006
Filed
Apr 30, 2026
Trade date
Apr 28-30, 2026
Filing delay
2 days
Rule 10b5-1 plan
Checked

This filing lists 10 non-derivative transactions and 4 derivative transactions. Open-market sales total $26.4M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Patel Sanj KCIK 0001532218Director, Officer (CHAIRMAN & CEO)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Apr 28, 2026Class A Ordinary ShareMOption exerciseAcquired+431,904$10.36+$4,474,525.44431,904Direct
Apr 28, 2026Class A Ordinary ShareMOption exerciseAcquired+51,750$30.93+$1,600,627.5483,654Direct
Apr 28, 2026Class A Ordinary ShareSSaleDisposed−74,635$50.43F2−$3,763,843.05409,019Direct
Apr 28, 2026Class A Ordinary ShareSSaleDisposed−113,673$51.47F3−$5,850,749.31295,346Direct
Apr 28, 2026Class A Ordinary ShareSSaleDisposed−243,596$52.02F4−$12,671,863.9251,750Direct
Apr 28, 2026Class A Ordinary ShareSSaleDisposed−51,750$54.02F5−$2,795,5350Direct
Apr 29, 2026Class A Ordinary ShareMOption exerciseAcquired+22,544$30.93+$697,285.9222,544Direct
Apr 29, 2026Class A Ordinary ShareSSaleDisposed−22,544$54.01F6−$1,217,601.440Direct
Apr 30, 2026Class A Ordinary ShareMOption exerciseAcquired+2,141$30.93+$66,221.132,141Direct
Apr 30, 2026Class A Ordinary ShareSSaleDisposed−2,141$54.01F7−$115,635.410Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Apr 28, 2026Class A Ordinary ShareMOption exerciseDisposed−431,904$0.00$00Direct
Apr 28, 2026Class A Ordinary ShareMOption exerciseDisposed−51,750$0.00$073,250Direct
Apr 29, 2026Class A Ordinary ShareMOption exerciseDisposed−22,544$0.00$050,706Direct
Apr 30, 2026Class A Ordinary ShareMOption exerciseDisposed−2,141$0.00$048,565Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

This transaction was executed in multiple trades through a broker-dealer at prices ranging between $50.00 and $50.985. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.

Referenced by the price of 1 transaction in Table I.

F3

This transaction was executed in multiple trades through a broker-dealer at prices ranging between $51.00 and $51.99. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.

Referenced by the price of 1 transaction in Table I.

F4

This transaction was executed in multiple trades through a broker-dealer at prices ranging between $52.00 and $52.58. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.

Referenced by the price of 1 transaction in Table I.

F5

This transaction was executed in multiple trades through a broker-dealer at prices ranging between $54.00 and $54.22. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.

Referenced by the price of 1 transaction in Table I.

F6

This transaction was executed in multiple trades through a broker-dealer at prices ranging between $54.00 and $54.225. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.

Referenced by the price of 1 transaction in Table I.

F7

This transaction was executed in multiple trades through a broker-dealer at prices ranging between $54.00 and $54.03. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)